SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: biao luo who wrote (3179)12/7/1997 2:26:00 AM
From: Peter Singleton  Read Replies (1) of 6136
 
Izzy, John,

From Biao Luo's post:

"Here is the article on In Vivo: The Business and Medicine Report
(September, 1997, Vol.15(8)), page 78

Agouron didn't invent Viracept. The drug came out
of Eli Lilly & Co.'s compound library, going to Agouron as part of the
January 1994 wrapping-up of the companies' disbanded 1988 alliance."
The publisher is Windhover Information Inc"

This should be easy to check. Is anyone familiar with Windhover, or with In Vivo? Has anyone asked AGPH?

IMO you guys were a little aggressive in chasing him off the board (if in fact that's what you've done). His second post on the matter is obviously more useful than his first of course ... but if this is being said in a circulated publication, it's worth knowing about, and it's true it's also an interesting data point.

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News